Singapore markets close in 5 hours 51 minutes

Innovative Pharmaceutical Biotech Limited (0399.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.210+0.010 (+5.00%)
As of 10:12AM HKT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
7,664
8,075
11,145
15,189
Cost of revenue
6,847
7,217
10,091
13,784
Gross profit
817
858
1,054
1,405
Operating expenses
Research development
11,336
4,758
8,246
6,092
Selling general and administrative
16,689
17,031
17,243
16,910
Total operating expenses
20,024
21,561
25,408
22,790
Operating income or loss
-19,207
-20,703
-24,354
-21,385
Interest expense
254,840
233,969
189,951
191,032
Income before tax
56,178
-254,671
36,431
-212,155
Income tax expense
0
0
0
0
Income from continuing operations
56,178
-254,671
36,431
-212,155
Net income
63,651
-245,698
45,803
-204,939
Net income available to common shareholders
63,651
-245,698
45,803
-204,939
Basic EPS
0.04
-0.17
0.03
-0.14
Diluted EPS
-0.11
-0.17
-0.04
-0.14
Basic average shares
1,464,193
1,464,193
1,464,193
1,464,193
Diluted average shares
1,607,193
1,464,193
1,750,193
1,464,193